Ionis Pharmaceuticals, Inc. (IONS) financial statements (2021 and earlier)

Company profile

Business Address 2855 GAZELLE COURT
CARLSBAD, CA 92010
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,5002,0841,023665779729657
Cash and cash equivalents68327913085129143160
Short-term investments1,8161,805893581650586497
Receivables  6310811411
Inventory, net of allowances, customer advances and progress billings189    
Inventory189     
Contract with customer, asset6313
Other current assets140102721515168
Other undisclosed current assets  1010328860
Total current assets:2,7212,2081,168798837837736
Noncurrent Assets
Property, plant and equipment15413212293908986
Long-term investments and receivables      1
Long-term investments      1
Intangible assets, net (including goodwill)262422   
Intangible assets, net (excluding goodwill)262422    
Deferred income tax assets306
Other noncurrent assets281310    
Deferred tax assets, net291     
Other undisclosed noncurrent assets   22293025
Total noncurrent assets:513460154115119119112
TOTAL ASSETS:3,2332,6681,322912956956847
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities15310611781736145
Accounts payable16292521281811
Accrued liabilities67486736283022
Employee-related liabilities37292524161212
Taxes payable33      
Deferred revenue118
Debt21421134
Deferred revenue and credits10651675248
Contract with customer, liability160
Other undisclosed current liabilities    9  
Total current liabilities:27328022513414911598
Noncurrent Liabilities
Long-term debt and lease obligation60628593   150
Long-term debt, excluding current maturities60628593   150
Liabilities, other than long-term debt4905677391134128143
Deferred revenue and credits7391134128143
Deferred revenue490
Contract with customer, liability567
Other undisclosed noncurrent liabilities72651358847245578
Total noncurrent liabilities:1,2761,200679679606583371
Total liabilities:1,5491,481903813755698469
Stockholders' equity
Stockholders' equity attributable to parent1,4711,048331100201258378
Common stock0000000
Additional paid in capital2,2042,0471,5501,3111,3091,2251,325
Accumulated other comprehensive income (loss)(25)(32)(32)(30)(14)4021
Accumulated deficit(708)(967)(1,187)(1,181)(1,095)(1,007)(968)
Stockholders' equity attributable to noncontrolling interest21313988    
Total stockholders' equity:1,6851,187419100201258378
TOTAL LIABILITIES AND EQUITY:3,2332,6681,322912956956847

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues1,123600508347284214147
Revenue, net113    
Cost of revenue(4)(2)     
Cost of goods and services sold(4)(2)     
Gross profit:1,118598508347284214147
Operating expenses(752)(661)(483)(393)(359)(262)(199)
Other undisclosed operating income 2     
Operating income (loss):366(61)25(46)(76)(48)(52)
Nonoperating income5230454242
Investment income, nonoperating5230854242
Other nonoperating expense(1)(0)(4)    
Interest and debt expense(71)(45)(45)(43)(37)(31)(19)
Other undisclosed loss from continuing operations before equity method investments, income taxes  (7)    
Income (loss) from continuing operations before equity method investments, income taxes:347(76)(23)(84)(108)(54)(69)
Other undisclosed income from continuing operations before income taxes   020 2
Income (loss) from continuing operations before income taxes:347(76)(23)(84)(88)(54)(67)
Income tax expense (benefit)(44)2916(3)(0)15 
Income (loss) before gain (loss) on sale of properties:303215(17)(87)(88)(39)(67)
Other undisclosed net income      6
Net income (loss):303215(17)(87)(88)(39)(61)
Net income (loss) attributable to noncontrolling interest(9)5911    
Net income (loss) attributable to parent:294274(6)(87)(88)(39)(61)
Other undisclosed net income available to common stockholders, basic2316    
Net income (loss) available to common stockholders, diluted:29727710(87)(88)(39)(61)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):303215(17)(87)(88)(39)(61)
Other comprehensive income (loss)7(0)(1)    
Comprehensive income (loss):310215(19)(87)(88)(39)(61)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(9)5911    
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   (17)(53)199
Comprehensive income (loss), net of tax, attributable to parent:301274(7)(103)(142)(20)(52)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: